India Coronavirus Dispatch: 64% of Uttar Pradesh villages 'Covid free'

A novel testing method by IISc-incubated startup, ICMR advises against indiscriminate use of home test kit, and more-news relevant to India's fight against Covid-19

coronavirus in rural India
Bharath Manjesh New Delhi
3 min read Last Updated : May 20 2021 | 2:17 PM IST
Over 275,000 fresh cases reported

India reported 276,110 fresh coronavirus infections on Thursday, taking the cumulative caseload to 25.7 million, according to central health ministry data. The country saw 3,874 deaths due to the pandemic, taking the death toll to 287,122. The active caseload is at 3.1 million, while the total recoveries have surged to 22.3 million. As many as 187 million shots have been administered since the nationwide inoculation programme kicked off on January 16. Of these, 1.1 million were given on Wednesday. Read more

64% of Uttar Pradesh’s villages Covid free: State govt

The Uttar Pradesh government has claimed that 64 per cent of its villages are completely free of Covid, based on the latest testing data, a report in The Indian Express said. With rural UP reporting more cases during the second wave, the government has claimed to have focused its efforts in rural areas to contain the spread of the virus. The state administration has also said a special sanitation campaign had started in rural areas to prevent the virus from spreading further, the report said. Read here

Karnataka: Staff crunch forces relatives to tend to Covid patients at a hospital

At the state-run Mandya Institute of Medical Sciences in Mandya, Karnataka, relatives have been forced to tend to Covid patients owing to a severe staff crunch, a report in ThePrint said. There were around 54 patients admitted in three of the several Covid wards. But each patient had an attendant right next to them, in violation of treatment protocols. The attendants were either sleeping on the floor in the same ward near their patients or sitting with just cloth masks on risking contracting the virus, the report said. Read more

India approves home test for Covid, to cost ₹250 per kit

India has greenlit the first home test for Covid that allows people to buy a kit that provides results within 15 minutes, a report in Hindustan Times said. The kit, which costs Rs 250 and is manufactured by Pune-based Mylab Discovery Solutions Ltd, is a rapid antigen test (RAT). It should only be used by people who have Covid symptoms or have had close contact with an infected person. “Indiscriminate testing is not advised. All individuals who test positive may be considered as true positives and no repeat testing is required," ICMR said. Read more

New Covid testing method by IISc-incubated startup gets regulatory approval

A novel Covid test developed by a startup incubated by the Indian Institute of Science (IISc) in Bengaluru has gotten regulatory approval and is expected to help detect the presence and the response of antibodies acting against coronavirus, even after vaccination, a report in The Indian Express said. Dr Navakanta Bhat, co-founder of the startup PathShodh Healthcare said that the capability to quantify the Covid antibody concentration will be key in estimating the declining antibody response over time. Read more

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story